Familial factors affecting prostatic cancer risk and plasma sex‐steroid levels

Prostate - Tập 6 Số 2 - Trang 121-128 - 1985
A.W. Meikle1, Joseph A. Smith1, Dee W. West1
1Departments of Internal Medicine, Urology and Family and Community Medicine, University of Utah School of Medicine, Salt Lake City

Tóm tắt

AbstractWhether familial factors affect the frequency of prostatic cancer and the plasma content of sex‐steroids was investigated. Brothers (n = 257) of probands (n = 150) diagnosed with prostatic cancer before age 62 years had a fourfold higher risk for developing the disease than men in the general population in the State of Utah and their brothers‐in‐law (n = 202). Familial factors markedly affected the plasma content of sex steroids (testosterone, dihydro‐testosterone, the ratio of testosterone to DHT, sex‐hormone binding globulin, and the free fraction of testosterone) in nonendocrinologically treated probands and their brothers and sons and in normal men in the general populations. Index cases and their brothers and sons had a significantly lower mean plasma testosterone content than controls of comparable age. Preliminary data suggest that the metabolic clearance rate of testosterone and the conversion ratio of testosterone to estradiol are relatively high in probands. The observations indicate that familial factors are potent risk factors for the development of prostatic cancer. They also suggest that plasma androgen values in families with prostatic cancer cluster in the lower range of normal and that plasma sex‐steroid content is more similar in each brothers with or without prostatic cancer than among nonbrothers.

Từ khóa


Tài liệu tham khảo

Moore RA, 1944, Benign hypertrophy and a carcinoma of the prostate. Occurrence and experimental production in animals, Surgery, 16, 152

Silverberg E, 1977, Cancer statistics, Cancer, 27, 26

10.1016/0021-9681(75)90029-6

Hutchinson GB, 1976, Epidemiology of prostatic cancer, Semin Oncol, 3, 151

10.1210/jcem-54-6-1104

10.1016/0026-0495(82)90019-1

10.1210/jcem-48-6-969

10.1210/jcem-29-11-1470

10.1172/JCI106185

10.1210/jcem-38-2-207

10.1093/ije/9.1.97

Donner A, 1980, The estimation of intraclass correlation in analysis of family data, Biometrics, 36, 19, 10.2307/2530491

Armitages P, 1977, Statistical Methods in Medical Research, 189

Cannon L, 1982, Genetic epidemiology of prostate cancer in the Utah Mormon Genealogy, Cancer Surv, 1, 47

10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E

Mortganti G, 1956, Recherches clinico‐statistiques et genetiques sur les neoplasies de la prostate, Acta Genet Stat, 6, 304

10.1002/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5

10.1056/NEJM197212212872508

Lipsett MB, 1977, The Human Testis, 407

Bardin CW, 1978, Reproductive Endocrinology, 110

10.1172/JCI106613

10.1172/JCI105344

Santen RJ, 1971, The Testis in Normal and Infertile Men, 197

Loriaux DL, 1977, The Testis in Normal and Infertile Men, 213

10.1210/jcem-35-4-535

Heyns W, 1977, The steroid‐binding β‐globulin of human plasma, Adv Steroid Biochem Pharmacol, 6, 59

Wenn RV, 1977, Human testosterone‐oestradiol binding globulin in health and disease, Acta Endocrinol, 84, 850

10.1016/0091-7435(80)90037-7

10.1016/0026-0495(79)90194-X

10.1056/NEJM197610072951501

10.1210/jcem-39-1-40

10.1016/0002-9343(74)90850-X

10.1210/jcem-34-4-730

Pirke KM, 1975, Age related changes in free plasma testosterone, dihydrotestosterone and estradiol, Acta Endocrinol (Kbh), 80, 171

10.1210/jcem-41-4-793

Pirke KM, 1973, Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone‐binding globulin in normal adult males, Acta Endocrinol (Kbh), 74, 792

10.1111/j.1365-2265.1976.tb01964.x

10.1210/jcem-45-4-695

10.1210/jcem-48-4-633

10.1016/0026-0495(82)90175-5

10.1210/jcem-45-6-1211

10.1210/jcem-47-2-268

10.1002/pros.2990030607

10.1016/S0022-5347(17)62795-2

Cowley TH, 1976, The effect of ACTH on plasma testosterone and androstenedione concentrations in patients with prostate carcinoma, Acta Endocrinol, 81, 310

Bartsch W, 1977, Sex hormone binding globulin‐binding capactity, testosterone, 5‐α‐dihydrotestosterone, oestradiol, and prolactin in plasma of patients with prostate carcinoma under various types of hormone treatment, Acta Endocrinol, 85, 650

Harper ME, 1976, Plasma steroid and protein hormone concentration in patients with prostatic carcinoma, before and during estrogen therapy, Acta Endocrinol, 81, 409

10.1677/joe.0.0710099

10.1136/bmj.4.5784.391

10.1002/pros.2990030407